Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-type virus
- 1 July 1986
- journal article
- research article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 24 (1) , 157-160
- https://doi.org/10.1128/jcm.24.1.157-160.1986
Abstract
To identify immunological predictors of resistance to influenza A infection and illness, the immunological status of live and inactivated virus vaccinees subsequently challenged with H1N1 or H3N2 wild-type virus was examined. We refer to prechallenge antibodies of vaccinees receiving live attenuated virus as infection induced and those receiving inactivated virus as inactivated vaccine induced. Inactivated vaccine-induced protection against wild-type virus infection or illness correlated with the level of neuraminidase-inhibiting antibody in serum, local hemagglutinin immunoglobulin G (IgG) (but not IgA) enzyme-linked immunosorbent assay antibody, and hemagglutination-inhibiting antibody in serum. In contrast, infection-indcued resistance to wild-type virus infection correlated with local hemagglutinin IgA antibody and neuraminidase-inhibiting antibody in serum, but not with hemagglutination-inhibiting antibody in serum. These observations suggest that live vaccine virus infection-induced and inactivated vaccine-induced immunity may involve different compartments of the immune system; sufficient antibody in either serum or nasal secretions is capable of conferring resistance.This publication has 23 references indexed in Scilit:
- ADVANTAGE OF LIVE ATTENUATED COLD-ADAPTED INFLUENZA A VIRUS OVER INACTIVATED VACCINE FOR A/WASHINGTON/80 (H3N2) WILD-TYPE VIRUS INFECTIONThe Lancet, 1984
- Cross‐protection in mice infected with influenza A virus by the respiratory route is correlated with local IgA antibody rather than serum antibody or cytotoxic T cell reactivityEuropean Journal of Immunology, 1984
- Viral Respiratory Disease at Lowry Air Force Base in Denver, 1952-1982The Journal of Infectious Diseases, 1983
- Some newly recognized aspects of resistance against and recovery from influenzaArchiv für die gesamte Virusforschung, 1982
- Protection of Infants from Infection with Influenza A Virus by Transplacentally Acquired AntibodyThe Journal of Infectious Diseases, 1980
- Evaluation of a Neuraminidase-Specific Influenza A Virus Vaccine in Children: Antibody Responses and Effects on Two Successive Outbreaks of Natural InfectionThe Journal of Infectious Diseases, 1979
- Induction of Partial Immunity to Influenza by a Neuraminidase-specific VaccineThe Journal of Infectious Diseases, 1974
- Temperature-Sensitive Mutants of Influenza Virus. III. Further Characterization of the ts-1[E] Influenza A Recombinant (H3N2) Virus in ManThe Journal of Infectious Diseases, 1973
- Inactivated vaccines. 2. Laboratory indices of protectionPresented by the senior author before the symposium on Influenza Vaccines, London, 27 April 1972.Published by Oxford University Press (OUP) ,1973
- STUDIES IN EXPERIMENTAL IMMUNOLOGY OF INFLUENZAImmunology & Cell Biology, 1950